Massive study aims to unlock secrets of rare blood disease survival
NCT ID NCT07205861
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 26 times
Summary
This study is looking back at the health records of over 1,200 people who survived a rare, life-threatening blood disorder called immune thrombotic thrombocytopenic purpura (iTTP). The goal is to understand their long-term health, especially heart and brain problems, and how different treatments affect their lives. By finding patterns, researchers hope to create better care plans for survivors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service d'Hématologie Hôpital Saint-Antoine
RECRUITINGParis, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.